Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Treatment of tobacco dependence in mental health and addictive disorders.

Hitsman B, Moss TG, Montoya ID, George TP.

Can J Psychiatry. 2009 Jun;54(6):368-78. Review.

2.

Predictors of early abstinence in smokers with schizophrenia.

Culhane MA, Schoenfeld DA, Barr RS, Cather C, Deckersbach T, Freudenreich O, Goff DC, Rigotti NA, Evins AE.

J Clin Psychiatry. 2008 Nov;69(11):1743-50. Epub 2008 Oct 21.

3.

Survey of clinician attitudes toward smoking cessation for psychiatric and substance abusing clients.

Weinberger AH, Reutenauer EL, Vessicchio JC, George TP.

J Addict Dis. 2008;27(1):55-63. doi: 10.1300/J069v27n01_06.

PMID:
18551888
4.

A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia.

George TP, Vessicchio JC, Sacco KA, Weinberger AH, Dudas MM, Allen TM, Creeden CL, Potenza MN, Feingold A, Jatlow PI.

Biol Psychiatry. 2008 Jun 1;63(11):1092-6. Epub 2007 Dec 21.

5.

Co-morbidity of smoking in patients with psychiatric and substance use disorders.

Kalman D, Morissette SB, George TP.

Am J Addict. 2005 Mar-Apr;14(2):106-23. Review.

6.

Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions.

Grant BF, Hasin DS, Chou SP, Stinson FS, Dawson DA.

Arch Gen Psychiatry. 2004 Nov;61(11):1107-15.

PMID:
15520358
7.

Extended nortriptyline and psychological treatment for cigarette smoking.

Hall SM, Humfleet GL, Reus VI, Muñoz RF, Cullen J.

Am J Psychiatry. 2004 Nov;161(11):2100-7.

PMID:
15514412
8.

The increasing recalcitrance of smokers in clinical trials II: Pharmacotherapy trials.

Irvin JE, Hendricks PS, Brandon TH.

Nicotine Tob Res. 2003 Feb;5(1):27-35.

PMID:
12745504
9.

A placebo controlled trial of bupropion for smoking cessation in schizophrenia.

George TP, Vessicchio JC, Termine A, Bregartner TA, Feingold A, Rounsaville BJ, Kosten TR.

Biol Psychiatry. 2002 Jul 1;52(1):53-61.

PMID:
12079730
10.

Incidence of cancer among persons with schizophrenia and their relatives.

Lichtermann D, Ekelund J, Pukkala E, Tanskanen A, Lönnqvist J.

Arch Gen Psychiatry. 2001 Jun;58(6):573-8.

PMID:
11386986
11.

Smoking and mental illness: A population-based prevalence study.

Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH.

JAMA. 2000 Nov 22-29;284(20):2606-10.

PMID:
11086367
12.

The increasing recalcitrance of smokers in clinical trials.

Irvin JE, Brandon TH.

Nicotine Tob Res. 2000 Feb;2(1):79-84. Review.

PMID:
11072444
13.

Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia.

George TP, Ziedonis DM, Feingold A, Pepper WT, Satterburg CA, Winkel J, Rounsaville BJ, Kosten TR.

Am J Psychiatry. 2000 Nov;157(11):1835-42.

PMID:
11058482
14.

The positive and negative syndrome scale (PANSS) for schizophrenia.

Kay SR, Fiszbein A, Opler LA.

Schizophr Bull. 1987;13(2):261-76.

PMID:
3616518
15.

The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire.

Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO.

Br J Addict. 1991 Sep;86(9):1119-27.

PMID:
1932883

Supplemental Content

Support Center